CHESTNUT RIDGE, N.Y., Aug. 3, 2015 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Friday, August 7, 2015 at 9:00 a.m. EDT to review its results of operations for the second quarter ended June 30, 2015. Par is privately held and currently makes certain financial information available to the public in its filings with the Securities and Exchange Commission and will make certain other information available on its website by following the instructions at http://www.parpharm.com/financialinfo. Par will file its financial statements for the quarter ended June 30, 2015 with the SEC prior to the call.
Only holders of Par's debt securities, prospective holders of Par's debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call by requesting access to the secured area of Par's website at http://www.parpharm.com/financialinfo for dial-in information.
About Par Pharmaceutical Companies, Inc.
Par is a specialty pharmaceutical company that develops, manufactures and markets safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life. Par Pharmaceutical offers a line of high-barrier-to-entry generic drugs, while Par Specialty Pharmaceuticals provides niche, innovative brands. Par Sterile Products develops, manufactures and markets both branded and generic aseptic injectable pharmaceuticals. For press release and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies, Inc.